Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

PMSA-untargeted cisplatin/irinotecan-loaded nanoparticles

Based on

1 Patents
2014 Most recent source

Composition

1

Alexa 488-labeling PLGA-PEG

Type Complex Compound
Formula
Role raw materials
2

(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate

irinotecan Camptosa CPT
Type Single Compound
Formula C33H38N4O6
Role loaded material
3

PLA-succinic acid-conjugated cisplatin

polylactic acid-cisplatin PLA-cisplatin
Type Polymer
Formula
Role loaded material

Properties

Applications

Characterization

Biological effects

Biological system Test details Source
human prostatic carcinoma PSMA-overexpressing LNCaP cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • Alexa 488-linked poly(lactic-co-glycolic acid)
  • PLA-succinic acid-conjugated cisplatin
  • (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate
See all (4)
  1. suqpCX5olc3fvIVp9xZJJu1s92C
Product

PMSA-untargeted cisplatin/irinotecan-loaded nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial